PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TAK vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between TAK and SPY is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

TAK vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Takeda Pharmaceutical Company Limited (TAK) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-6.12%
9.83%
TAK
SPY

Key characteristics

Sharpe Ratio

TAK:

-0.07

SPY:

1.97

Sortino Ratio

TAK:

0.02

SPY:

2.64

Omega Ratio

TAK:

1.00

SPY:

1.36

Calmar Ratio

TAK:

-0.03

SPY:

2.97

Martin Ratio

TAK:

-0.18

SPY:

12.34

Ulcer Index

TAK:

7.35%

SPY:

2.03%

Daily Std Dev

TAK:

17.49%

SPY:

12.68%

Max Drawdown

TAK:

-52.76%

SPY:

-55.19%

Current Drawdown

TAK:

-39.27%

SPY:

-0.01%

Returns By Period

In the year-to-date period, TAK achieves a 2.27% return, which is significantly lower than SPY's 4.03% return. Over the past 10 years, TAK has underperformed SPY with an annualized return of -1.39%, while SPY has yielded a comparatively higher 13.18% annualized return.


TAK

YTD

2.27%

1M

4.80%

6M

-5.86%

1Y

-3.19%

5Y*

-2.53%

10Y*

-1.39%

SPY

YTD

4.03%

1M

2.03%

6M

9.65%

1Y

23.63%

5Y*

14.28%

10Y*

13.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TAK vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TAK
The Risk-Adjusted Performance Rank of TAK is 3737
Overall Rank
The Sharpe Ratio Rank of TAK is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of TAK is 3131
Sortino Ratio Rank
The Omega Ratio Rank of TAK is 3131
Omega Ratio Rank
The Calmar Ratio Rank of TAK is 4242
Calmar Ratio Rank
The Martin Ratio Rank of TAK is 4040
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7979
Overall Rank
The Sharpe Ratio Rank of SPY is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7676
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7878
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 8080
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TAK vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Takeda Pharmaceutical Company Limited (TAK) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TAK, currently valued at -0.07, compared to the broader market-2.000.002.004.00-0.071.97
The chart of Sortino ratio for TAK, currently valued at 0.02, compared to the broader market-6.00-4.00-2.000.002.004.006.000.022.64
The chart of Omega ratio for TAK, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.36
The chart of Calmar ratio for TAK, currently valued at -0.03, compared to the broader market0.002.004.006.00-0.032.97
The chart of Martin ratio for TAK, currently valued at -0.18, compared to the broader market-10.000.0010.0020.0030.00-0.1812.34
TAK
SPY

The current TAK Sharpe Ratio is -0.07, which is lower than the SPY Sharpe Ratio of 1.97. The chart below compares the historical Sharpe Ratios of TAK and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.07
1.97
TAK
SPY

Dividends

TAK vs. SPY - Dividend Comparison

TAK's dividend yield for the trailing twelve months is around 4.68%, more than SPY's 1.16% yield.


TTM20242023202220212020201920182017201620152014
TAK
Takeda Pharmaceutical Company Limited
4.68%4.78%4.41%3.69%5.80%3.84%4.94%8.33%5.14%6.91%5.34%5.03%
SPY
SPDR S&P 500 ETF
1.16%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

TAK vs. SPY - Drawdown Comparison

The maximum TAK drawdown since its inception was -52.76%, roughly equal to the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for TAK and SPY. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-39.27%
-0.01%
TAK
SPY

Volatility

TAK vs. SPY - Volatility Comparison

Takeda Pharmaceutical Company Limited (TAK) has a higher volatility of 6.62% compared to SPDR S&P 500 ETF (SPY) at 3.15%. This indicates that TAK's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%SeptemberOctoberNovemberDecember2025February
6.62%
3.15%
TAK
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab